ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 551

Different Cell Death Programs Contribute To Severity Of Lupus Glomerulonephritis In Males and Females

Neelakshi Jog1 and Roberto Caricchio2, 1Rheumatology, Temple University, Philadelphia, PA, 2Medicine/Rheumatology, Temple University, Philadelphia, PA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Apoptosis, cytokines, hormones and lupus nephritis, Lupus

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: Lupus glomerulonephritis (GN) is a leading cause of long-term disability in SLE. Although lupus is more common in females, GN occurs earlier and in a more accelerated manner in males. We propose that the severity of renal damage is defined by differences in cell death program during GN. Necrosis, a pro-inflammatory form of cell death can be regulated by two mediators: 1) Poly (ADP-Ribose) Polymerase-1 (PARP-1) and 2) Receptor Interacting Protein kinase 1/3 (RIP1/3). We demonstrated previously that the protection conferred by the absence or inhibition of PARP-1 from immune-mediated nephritis shows a sex-bias, with only male mice being protected. Several studies have shown that the response of males and females to stress differs. We therefore hypothesized that these differences might be due to cell death programs in the two sexes.

Methods:

We used an established model of immune complex mediated nephritis to investigate cell death in vivo and an in vitro system where bone marrow cells were allowed to differentiate in vitro into macrophages in presence or absence of estrogens. The cells were stimulated by hydrogen peroxide or toll-like receptor ligand (TLR), lipopolysaccharide (LPS). Cell death was measured by flow cytometry and morphology; cytokine were measured by quantitative PCR.

Results: We demonstrate that during nephritis, females show increased apoptotic cell death in the kidney compared to males. We also show that estrogen treatment in males induced similar levels of apoptosis as in females and importantly inhibited necrosis.  Although PARP-1 was activated in both males and females, PARP-1 inhibition decreased necrosis only in males. Interestingly inhibition of RIP1 with Necrostatin-1 did not show sex bias. To understand whether male and female cells show a differential cytokine expression pattern that may further contribute to the differences in cell death, we determined cytokine gene expression by bone marrow derived macrophages from male and female cells in response to TLR ligation in presence or absence of estrogens. We found that the expression of pro-inflammatory cytokines TNF alpha and MCP-1 were higher in male cells in absence of estrogens compared to females, suggesting that these cytokines may contribute to increased necrosis observed in males. We also observed that estrogens increased IL10 production in male cells upon TLR ligation. Interestingly IL10 has been previously shown to inhibit necrosis. Finally we found that estrogens reduced the levels of pro-inflammatory cytokines TNF alpha and MCP1.

Conclusion:

Taken together our data suggest that males and females differ in their susceptibility to pro-inflammatory cell death, i.e. propensity toward necrosis in males and apoptosis in females. The contributing factors to this dichotomy are the effective activation of necrotic cell death, hormones and pro-inflammatory cytokines. Our results might help understanding the increased severity of lupus nephritis in males and develop novel therapeutic strategies based on sex.


Disclosure:

N. Jog,
None;

R. Caricchio,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/different-cell-death-programs-contribute-to-severity-of-lupus-glomerulonephritis-in-males-and-females/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology